Related Experiment Video
Updated: Jan 3, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Worldwide burden of LDL cholesterol: Implications in cardiovascular disease
Camilla Mattiuzzi1, Fabian Sanchis-Gomar2, Giuseppe Lippi3
1Service of Clinical Governance, Provincial Agency for Social and Sanitary Services, Trento, Italy.
Insights
High low-density lipoprotein cholesterol (LDL-C) significantly impacts global health, causing millions of deaths and disability-adjusted life years (DALYs). Urgent healthcare policies are needed to address this growing cardiovascular disease risk factor.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Elevated low-density lipoprotein cholesterol (LDL-C) is a primary risk factor for cardiovascular disease (CVD).
- LDL-C is integral to global CVD risk prediction and prevention guidelines.
- This study provides an overview of the global healthcare burden attributed to LDL-C.
Purpose of the Study:
- To assess the worldwide adverse healthcare impact of elevated low-density lipoprotein cholesterol (LDL-C).
Main Methods:
- Epidemiological data on LDL-C levels exceeding 1.3 mmol/L were sourced from the Global Health Data Exchange (GHDx) registry.
- Analysis focused on disability-adjusted life years (DALYs) and mortality attributable to high LDL-C.
Main Results:
- The current global burden is 94.92 million DALYs, with an exponential increase over the last 25 years.
- 4.32 million deaths are linked to LDL-C levels above 1.3 mmol/L.
- DALYs and deaths from LDL-C have risen globally, except in high socio-demographic index countries.
Conclusions:
- Effective, large-scale healthcare policies are essential to combat the epidemic of LDL-C-related health loss.
- Addressing high LDL-C is critical for global cardiovascular health and reducing disease burden.
Background And Aim:
an increased value of low-density lipoprotein cholesterol (LDL-C) is now universally considered a major cardiovascular disease (CVD) risk factor. LDL-C is included in the vast majority of worldwide cardiovascular risk prediction algorithms, as well as in the guidelines for cardiovascular risk prevention. We aimed to provide an overview of the worldwide adverse healthcare impact of low-density lipoprotein cholesterol (LDL-C).
Methods And Results:
Data on the epidemiologic burden of LDL-C >1.3 mmol/L were retrieved from Global Health Data Exchange (GHDx) registry. The current burden is 94.92 million disability-adjusted life years (DALYs), with an exponential increase occurred during the past 25 years. 4.32 million deaths can be attributed to LDL cholesterol values > 1.3 mmol/L. DALYs and deaths due to LDL-C have significantly increased in all countries except those with high socio-demographic index.
Conclusion:
More effective structural healthcare policies shall be planned at a worldwide scale for contrasting the epidemics of LDL-C attributable heath loss.
Related Concept Videos
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction

